Navigation Links
Randomized Clinical Trial of OrbusNeich's Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
Date:10/11/2010

HONG KONG, Oct. 11 /PRNewswire/ -- OrbusNeich today reported the completion of patient enrollment in a randomized clinical study of its Genous Bio-engineered R stent at 11 sites in China.

The primary objective of the 180 patient, controlled study is to demonstrate the safety and effectiveness of the Genous Bio-engineered R stent compared to the Medtronic Endeavor® Sprint stent in patients with symptoms of angina or myocardial ischemia. The primary endpoints are difference in Major Adverse Cardiac Event (MACE) rates between the two groups at 12 months after implantation and 270 day angiographic Late Loss (LL). Patients enrolled in the study were split evenly between the control and test arms.

"Based on its unique design and healing technology, we believe that Genous has the potential to give physicians an additional option for treating patients," said Prof. Lu Shuzheng from Anzhen Hospital, principal investigator of the trial. "We are excited to complete enrollment in this study, which may bring further clinical support for the technology's use in China."

David Chien, vice chairman of OrbusNeich, added, "This first clinical study of Genous in China is significant in the full development of the technology. We look forward to seeing additional clinical support for the use of Genous in challenging cases, such as diabetic patients and those who cannot tolerate a year of dual antiplatelet therapy."

Secondary endpoints include all-cause and cardiac mortality, myocardial infarction, in-stent thrombosis, MACE rates at 30, 60, 90, 180 and 270 days, as well as clinically driven Target Lesion Revascularization (TLR), Target Vessel Revascularization (TVR) and Target Lesion Failure (TLF) rates at 30, 60, 90, 180, 270 and 360 days.  

About Genous

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeichs Combo™ Bio-engineered Sirolimus Eluting Stent
2. National University Hospital Singapore Receives DSRB Approval to Use TIGR® Matrix Surgical Mesh in a New Randomized Controlled TRAM Flap Study
3. CorMatrix Receives FDA IDE Approval to Begin Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM™ for Pericardial Closure
4. Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery
5. ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
6. Ophthotech Enrolls Its First Patient in a Randomized, Controlled Phase II Study of E10030 in Macular Degeneration
7. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
8. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
9. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
10. West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
11. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Una presentazione speciale durante la settimana della ... di MERG valutare i successi ottenuti grazie ... svariate popolazioni di pazienti affetti dalla patologia. ... Ronnie Fass , MD della Case Western Reserve University, ... relativi alla terapia Stretta. Un panel di esperti ha ...
(Date:5/27/2015)... Biosensors International Group, Ltd. ("Biosensors " or ... a developer, manufacturer and marketer of innovative medical devices, ... ("Q4 FY15") and fiscal full year ended 31 March ... , Q4 FY15: , Total revenue ... of Fiscal Year 2014 ("Q4 FY14") due to licensing ...
(Date:5/27/2015)... VILLAGE, Nev. , May 27, 2015  PDL ... that John P. McLaughlin , the company,s president ... 2015 Global Healthcare Conference next week in New York ... on Wednesday, June 3, 2015 at 11:30 a.m. EDT. ... webcast of the presentation, go to the Company,s website ...
Breaking Medicine Technology:Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 2Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 3Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 4Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2
... , SAN CARLOS, Calif., Nov. 30 ... promotion of Lorianne Masuoka, M.D. to Senior Vice President ... directly to Nektar,s President and Chief Executive Officer, Howard ... highly effective clinical development strategies have been instrumental in ...
... , CHICAGO, Nov. 30 Breast-Specific Gamma Imaging ... high-risk lesions in patients with negative or indeterminate mammographic ... today at the annual meeting of the Radiological Society ... BSGI was conducted as an adjunct diagnostic imaging modality ...
Cached Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2
(Date:5/27/2015)... Valley, CA (PRWEB) May 27, 2015 For ... Dr. Peyman Ghasri, is now offering discounts on facial fillers. ... year after the age of 18. This lost collagen can ... sunken cheeks, wrinkles and expression lines. Facial fillers are an ... Many people turn to facial fillers to create a softer ...
(Date:5/27/2015)... 27, 2015 Decorview , a ... is offering free design advice to homeowners looking to ... , “Light pollution caused by streetlights, outdoor signs, full ... night’s sleep, said Kim Rush, VP of sales and ... across North America with recently installed LED streetlights– the ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
(Date:5/27/2015)... May 27, 2015 Altec Products, Inc., ... announced today their Premier Sponsorship of Connections 2015. The ... Hilton on Thursday, May 28th and will deliver to ... well as the roadmap to get there. , ... in the sale, installation and support of Intacct Cloud ...
(Date:5/27/2015)... 27, 2015 With the FCPX LUT ... can quickly and easily add filmic color grades to their ... files. , FCPX LUT Cross Processed Plugin can instantly make ... looks and everything in between. , FCPX LUT Cross Processed ... in many different softwares. With the FCPX LUT Cross Processed ...
Breaking Medicine News(10 mins):Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:CRN International Names New Chief Financial Officer 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2
... ABT ),will present at the Citi Investment Research ... C. Freyman, executive vice president,finance and chief financial officer, ... Central time., A live audio webcast of the ... at http://www.abbottinvestor.com . An,archived edition of the presentation ...
... With the economy tight and,sales forces shrinking across ... maintain an effective sales force. Regardless, a company,s ... success going forward. That,success is predicated on establishing ... goals and managing groups in a way,that meets ...
... increase the risk of Alzheimers Disease by as much as ... issue of Obesity Reviews. , But its not just weight ... have an elevated risk of dementia, unlike people who are ... detailed review of 10 international studies published since 1995, covering ...
... staffing company to launch nationally-syndicated television ... ... Access,Nurses announced today a national campaign to change the image of nursing,in ... lives of nurses working on the front lines of modern,healthcare. The show, ...
... May 7 Emageon Inc. (Nasdaq:,EMAG), a leader in ... imaging facilities, will hold its,quarterly conference call to discuss ... at 10:00 AM Eastern Time. The company anticipates,that these ... the NASDAQ,stock market opens on May 12, 2008., ...
... May 7 AMDL, Inc. (Amex: ... in Shenzhen, Jiangxi,and Jilin, China, is a ... its subsidiary Jade Pharmaceutical Inc. (JPI),the Company ... of diagnostic, pharmaceutical, nutritional supplement, and,cosmetic products., ...
Cached Medicine News:Health News:Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies 2Health News:Obesity can increase dementia risk by up to 80 percent 2Health News:Nursing Shortage Spurs Campaign to Change the Image of Nursing in the Media 2Health News:Emageon Inc. to Host First Quarter 2008 Financial Results Conference Call May 12, 2008 2Health News:AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company 2Health News:AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: